| AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion (NCT04099966) | Mitchell Cairo | 2021-04-01 |
| Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients (NCT04834856) | Molecular Partners AG | 2021-04-01 |
| PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer (NCT04815408) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-04-01 |
| A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects (NCT04801017) | Oncotelic Inc. | 2021-04-01 |
| Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae (NCT04790565) | Rambam Health Care Campus | 2021-04-01 |
| The Effect of Vitamin D3 Therapy on Vitamin D Status in Pregnant Women With Vitamin D Deficient and Insufficient (NCT06054919) | Indonesia University | 2021-04-01 |
| Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases (NCT04801342) | National Taiwan University Hospital | 2021-04-01 |
| Rifampicin at High Dose for Difficult-to-Treat Tuberculosis (NCT04768231) | Hospital Universitari Vall d'Hebron Research Institute | 2021-04-01 |
| Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms (NCT04734860) | Sorrento Therapeutics, Inc. | 2021-04-01 |
| Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest. (NCT05044728) | Sichuan Cancer Hospital and Research Institute | 2021-04-01 |
| Investigation of the Efficacy and Safety of Three Test Products and Comparator on Muscular Performance After the Initiation of a Resistance Training Program (NCT04814225) | Roquette Canada, LTD. | 2021-04-01 |
| Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma (NCT04797182) | Sun Yat-sen University | 2021-04-01 |
| Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss (NCT04701333) | Stanford University | 2021-04-01 |
| Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients (NCT04943224) | Anna Raciborska | 2021-04-01 |
| Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19 (NCT04828564) | The Scientific and Technological Research Council of Turkey | 2021-04-01 |
| Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma (NCT04479527) | Peking University Cancer Hospital & Institute | 2021-04-01 |
| Effect of Frankincense Extract Gel on Non-Surgical Treatment of Chronic Periodontitis (NCT05005767) | Tanta University | 2021-04-01 |
| Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma (NCT04899570) | Peking Union Medical College Hospital | 2021-04-01 |
| Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer (NCT04831437) | Tehran University of Medical Sciences | 2021-04-01 |
| Phase II Study of Immunomaintenance Using POmalidomide With Elotuzumab afteR Second Autologous Transplant (NCT04584307) | Natalie Callendar | 2021-04-01 |
| CBD for Sleep in People With HIV (NCT05097651) | Mariana Cherner, PhD | 2021-04-01 |
| Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria (NCT03201939) | Vanderbilt University Medical Center | 2021-04-01 |
| Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma (NCT04824352) | Peking University People's Hospital | 2021-04-01 |
| A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma：The POTENTIAL Study (NCT04814069) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2021-04-01 |
| A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell Lymphoma (NCT04827004) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-04-01 |
| A Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma (NCT04705090) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2021-04-01 |
| Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL (NCT04835870) | The First Affiliated Hospital of Soochow University | 2021-04-01 |
| A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer (NCT04868708) | Akeso | 2021-04-01 |
| Reducing Innate Inflammation in New Onset Type 1 Diabetes (NCT04335656) | Medical College of Wisconsin | 2021-04-01 |
| Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation (NCT04712435) | Instituto Brasileiro de Controle do Cancer | 2021-04-01 |
| Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease (NCT04497168) | University of Michigan | 2021-04-01 |
| Local Therapy for ER/PR-positive Oligometastatic Breast Cancer (NCT04698252) | Instituto do Cancer do Estado de São Paulo | 2021-04-01 |
| Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma (NCT04526080) | Wake Forest University Health Sciences | 2021-04-01 |
| The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression (NCT04602715) | NuBiyota | 2021-04-01 |
| Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma (NCT04682158) | Roswell Park Cancer Institute | 2021-04-01 |
| Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers (NCT04795596) | Menoufia University | 2021-04-01 |
| A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC (NCT04803539) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-04-01 |
| Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19 (NCT04738175) | Sorrento Therapeutics, Inc. | 2021-04-01 |
| Intradermal COVID-19 Vaccination in the Immunocompromised (NCT05736913) | The University of Hong Kong | 2021-04-01 |
| Neuroinflammation in Patients With OCD (NCT04786548) | New York State Psychiatric Institute | 2021-04-01 |
| Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery (NCT05844371) | Yixing People's Hospital | 2021-04-01 |
| The Transformation of Locally Advanced Pancreatic Cancer. (NCT04723030) | Peking University | 2021-04-01 |
| Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality (NCT04492553) | Lars Møller Pedersen | 2021-04-01 |
| Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma (NCT04813523) | Tianjin Medical University Cancer Institute and Hospital | 2021-04-01 |
| Placenta Extract Gel as a Periodontal Local Delivery Drug (NCT06506539) | Suez Canal University | 2021-04-01 |
| PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL (NCT04624984) | Sun Yat-sen University | 2021-04-01 |
| Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant (NCT04418466) | Delpor, Inc. | 2021-04-01 |
| Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus (NCT04781816) | Sanofi | 2021-04-01 |
| A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19. (NCT04847544) | Aldeyra Therapeutics, Inc. | 2021-03-31 |
| Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer (NCT04670978) | Shandong University | 2021-03-31 |
| Treating Negative Affect in Low Back Pain Patients (NCT04747314) | Ajay Wasan, MD, Msc | 2021-03-31 |
| A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer (NCT04267237) | Hoffmann-La Roche | 2021-03-31 |
| Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants (NCT04495010) | Bristol-Myers Squibb | 2021-03-31 |
| Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. (NCT04812535) | InflaRx GmbH | 2021-03-31 |
| Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer (NCT04836728) | Tianjin Medical University Cancer Institute and Hospital | 2021-03-31 |
| Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease (NCT04838860) | RECORDATI GROUP | 2021-03-31 |
| Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (NCT04732494) | BeiGene | 2021-03-31 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures (NCT04519645) | UCB Biopharma SRL | 2021-03-31 |
| Use of Beetroot Juice to Protect Against Postoperative Ileus Following Colorectal Surgery: BEET IT Study (NCT05133024) | University Hospital, Ghent | 2021-03-31 |
| Alberta Back Care Pathway (ABCp) (NCT05452876) | University of Alberta | 2021-03-31 |
| Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) (NCT04409873) | University of California, San Francisco | 2021-03-31 |
| Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL (NCT04796857) | Huiqiang Huang | 2021-03-31 |
| Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction (NCT03678467) | Epibone, Inc. | 2021-03-31 |
| Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical Pain (NCT04011163) | KK Women's and Children's Hospital | 2021-03-31 |
| A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD) (NCT04299464) | Hoffmann-La Roche | 2021-03-31 |
| TL-895 and KRT-232 Study in Acute Myeloid Leukemia (NCT04669067) | Telios Pharma, Inc. | 2021-03-31 |
| Phentermine/Topiramate for Uric Acid Stones (NCT04621929) | University of Florida | 2021-03-31 |
| Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension). (NCT04830397) | Qlaris Bio, Inc. | 2021-03-31 |
| Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (NCT03915678) | Institut Bergonié | 2021-03-31 |
| Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias (NCT04786223) | Val Lowe | 2021-03-30 |
| Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) (NCT04484142) | Daiichi Sankyo | 2021-03-30 |
| Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction (NCT06250894) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-03-30 |
| Accelerated Radio-Immunotherapy for Lung Cancer (NCT04577638) | Center Eugene Marquis | 2021-03-30 |
| Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA (NCT04798339) | H. Lee Moffitt Cancer Center and Research Institute | 2021-03-30 |
| Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases (NCT04461418) | AHS Cancer Control Alberta | 2021-03-30 |
| Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema (NCT04600362) | Technical University of Munich | 2021-03-30 |
| A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection (NCT04847440) | Antios Therapeutics, Inc | 2021-03-30 |
| A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT (NCT04766892) | Bristol-Myers Squibb | 2021-03-30 |
| Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy (NCT04703686) | The Lymphoma Academic Research Organisation | 2021-03-30 |
| A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder (NCT04832425) | Praxis Precision Medicines | 2021-03-30 |
| The Effect of Colostrum Bovinum Supplementation in Endurance Athletes (NCT06390670) | Poznan University of Physical Education | 2021-03-30 |
| A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma (NCT04831658) | Mingzhi Zhang | 2021-03-29 |
| Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors (NCT04659603) | Sanofi | 2021-03-29 |
| Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies (NCT04785287) | M.D. Anderson Cancer Center | 2021-03-29 |
| Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy (NCT04855240) | ACADIA Pharmaceuticals Inc. | 2021-03-29 |
| A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase (NCT04825860) | Sumitomo Pharma Co., Ltd. | 2021-03-29 |
| HSK7653 in Chinese Patients with Impaired Glucose Tolerance (NCT04727580) | Haisco Pharmaceutical Group Co., Ltd. | 2021-03-29 |
| Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab (NCT04790695) | Ottawa Hospital Research Institute | 2021-03-29 |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors (NCT04673942) | EpicentRx, Inc. | 2021-03-29 |
| The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients (NCT04701606) | Shin Poong Pharmaceutical Co. Ltd. | 2021-03-29 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia (NCT04849988) | AEON Biopharma, Inc. | 2021-03-29 |
| Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients (NCT04838821) | Caja Costarricense de Seguro Social | 2021-03-29 |
| DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma (NCT04696029) | Giselle Sholler | 2021-03-29 |
| AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT04673617) | Artiva Biotherapeutics, Inc. | 2021-03-29 |
| Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250) (NCT04768296) | EMD Serono Research & Development Institute, Inc. | 2021-03-29 |
| Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor (NCT04800627) | M.D. Anderson Cancer Center | 2021-03-29 |
| CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) (NCT04684641) | Yale University | 2021-03-29 |
| Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) (NCT04098718) | University of Oxford | 2021-03-29 |
| Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC (NCT04260126) | PDS Biotechnology Corp. | 2021-03-29 |
| The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes (NCT04799327) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-29 |